← FDATracker
HomeAdverse Events

REVATIO Adverse Event: Unevaluable event

REVATIO Adverse Event: Unevaluable event is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVATIO; Product category: Drug; Primary reaction: Unevaluable event.

Primary drugREVATIO
Product categoryDrug
Primary reactionUnevaluable event
All reactionsUnevaluable event; Nasopharyngitis; Malaise; Cough
SeriousnessNot serious
Patient outcomeUnknown
Patient sexMale
All drugs reportedREVATIO; LETAIRIS; TYVASO
Reporter countryUS
Reporter type5
Report date20140312
Report ID10003447

🔍 Search all adverse events →